US20080113333A1 - Method for preventing the adhesion of particles - Google Patents
Method for preventing the adhesion of particles Download PDFInfo
- Publication number
- US20080113333A1 US20080113333A1 US11/854,792 US85479207A US2008113333A1 US 20080113333 A1 US20080113333 A1 US 20080113333A1 US 85479207 A US85479207 A US 85479207A US 2008113333 A1 US2008113333 A1 US 2008113333A1
- Authority
- US
- United States
- Prior art keywords
- cells
- particles
- canceled
- solution
- polyvinyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000001413 cellular effect Effects 0.000 claims abstract description 15
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 38
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 37
- 238000004452 microanalysis Methods 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 16
- 239000011521 glass Substances 0.000 claims description 10
- -1 polypropylene Polymers 0.000 claims description 8
- 150000002632 lipids Chemical class 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 229920000620 organic polymer Polymers 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 239000011859 microparticle Substances 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 claims description 2
- 229920002292 Nylon 6 Polymers 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920006362 Teflon® Polymers 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 210000000170 cell membrane Anatomy 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 75
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 35
- 239000000243 solution Substances 0.000 description 31
- 239000000872 buffer Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 7
- 229960000367 inositol Drugs 0.000 description 7
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 7
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 229920001917 Ficoll Polymers 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229920001477 hydrophilic polymer Polymers 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 230000000181 anti-adherent effect Effects 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005206 flow analysis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 230000025611 cell-substrate adhesion Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000002107 sheath cell Anatomy 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Definitions
- the invention relates to a method for the prevention of the adhesion of particles, in particular of cells and cellular components, to surfaces, whereby a polyalcohol is added to the solution which contains the particles.
- the adherence to surfaces is a fundamental property of cells. This becomes apparent, for example, in the interaction of cells with an extracellular matrix, which is an important factor in controlling the gene expression or general cell function. These processes are influenced in particular via proteins on the cell surface.
- hydrophobic silanes and hydrophilic polymers (hydrogels) are used for this purpose.
- copolymer particles from poly(methyl methacrylate) and polyvinyl alcohol do not adhere to blood cells and are not phagocyted by monocytes and neutrophiles (Ayhan, H. and E. Piskin (1997): “Interaction of activated leukocytes with polymeric microspheres” in “International Journal of Artificial Organs” 20(12), 704-707).
- the method comprises according to the invention the addition of a substance to the solution that contains the particles, particularly cells or cellular components, but also, for example, may contain proteins and peptides, that are present in the free form or bound to structures such as, for example beads.
- This substance according to the invention causes the adherence of these particles to surfaces, particularly surfaces of a microanalysis system, to be essentially prevented.
- FIG. 1 a diagram is shown that illustrates the recovery rate of suspended Jurkat cells from a microliter-syringe versus the residence time t in the presence of 0.5% PVA.
- this substance involves a polyalcohol, in particular polyvinyl alcohol, for example polyvinyl alcohol VA 30,000-70,000 and/or polyglycol, preferably polyethylene glycol.
- polyvinyl alcohol for example polyvinyl alcohol VA 30,000-70,000 and/or polyglycol, preferably polyethylene glycol.
- a concentration of the polyalcohol in solution of 0.01% (w/v) to 5% (w/v).
- polyvinyl alcohol it could even be shown, that the anti-adhesion effect of the polyalcohol by far exceeds that of known substances that are used as anti-adhesives (table 3).
- the water solubility and additional properties, listed below, of the polyalcohol cause a universal applicability in all aqueous particle solutions.
- optical signals such as, for example, fluorescence correlation spectroscopy, fluorescence resonance energy transfer, fluorescence polarization, fluorescence intensity distribution analysis, or, for example, UV-spectroscopy. Therefore, it was all the more important for the universal applicability of this substance, that it does not influence an optical analysis, i.e. particularly does not show autofluorescence or change the refractive index of the solution.
- polyalcohols particularly polyvinyl alcohols or polyglycols.
- the method according to the invention now allows an essentially loss-free examination and manipulation, particularly separation, of the particles, particularly in microanalysis systems.
- microanalysis systems that have, for example, channels with a height of from 1-1,000 ⁇ m, particularly 2-500 ⁇ m, especially preferred 40 ⁇ m; a width of 100 -2,000 ⁇ m, particularly 200-600 ⁇ m, and a length of 100 ⁇ m-10 cm, preferably 1-2 cm.
- the systems may consist in particular of glass, silicon, silicone, organic polymers, or another suitable material.
- Specific embodiments of the microanalysis systems may also have electrodes, in particular for the generation of dielectric forces for the manipulation of the particles that are to be examined, for example for the microscopic, optical and/or electrical analyzing, for the sorting, separating, electroporating, fusing and separating of the particles, particularly of cells.
- Microanalysis systems thus comprise electrodes as dielectric junctions in the microchannels for the sorting of suspended particles (in particular cells), or in other microanalysis systems the electrodes are arranged in such a way that the cell fusion and/or cell poration can be carried out, and other systems comprise two electrode levels in a closed microchannel, a dielectric field cage in a channel intersection as well as electrodes developed as dielectric junctions for the implementation of a stop-flow analysis as well as a subsequent sorting of the analyzed particles.
- the microchannel systems may also comprise combinations of the various electrode systems.
- the added substance according to the invention also does not influence a living cell, it is, for example, possible, to directly examine cells, to sort on the basis of the examinations and then to specifically recreate cell cultures with the separated cells. That way, for example, cells with a certain property, for instance with a certain kind of receptors on the cell surface, are specifically and essentially loss-free separated from other cells and multiplied.
- the method according to the invention is in general suitable for all cell types, consequently both for eukaryotic cells and for prokaryotic cells.
- the method according to the invention is likewise suitable for cellular components. It has no influence on their structure and does not cause degeneration. Under cellular components are to be understood, for example, liposomes, lipid membranes, lipids, proteins, DNA, nucleic acids, messenger substances, sugar, glycans, and/or glycoproteins. In principle, all components of a cell are thus concerned, but also cell fragments.
- the method according to the invention provides, besides the advantage that it prevents an adherence of the particles to the surfaces of microanalysis systems, that may in particular consist of silicon, silicone, glass, and/or organic polymers such as PMMA, polyurethane, polycarbonate, polypropylene, polystyrene, polyethylene, polyvinyl chloride, Teflon®, polyacryl (fiber), nylon®, and/or perlon®, also the possibility that it prevents the adhesion of biomolecules, in particular cells, cell membranes, cellular components such as lipids, proteins (in particular antibodies), DNA, nucleic acids, messenger substances, biotin, sugar, glycans, and/or glycoproteins among one another or to surfaces coated with such molecules.
- microanalysis systems may in particular consist of silicon, silicone, glass, and/or organic polymers such as PMMA, polyurethane, polycarbonate, polypropylene, polystyrene, polyethylene, polyvinyl chloride, Teflon®, polyacryl (fiber), nylon
- surface any surface, but in particular channel surfaces, surfaces of storage containers of microanalysis systems, tubing, syringes, injection modules, or surfaces of synthetic microparticles.
- This solution contains saline buffer, in particular PBS, and/or inositol, and polyvinyl alcohol.
- saline buffer in particular PBS, and/or inositol, and polyvinyl alcohol.
- PBS saline buffer
- inositol in particular PBS
- polyvinyl alcohol polyvinyl alcohol
- to the solution may also be added other components known in the context of cell solutions such as, for example, magnesium and calcium ions.
- the portions of saline buffer, inositol, and/or PVA are variable.
- the buffer may be diluted in a variable mixing ratio by normoosmolar, hyperosmolar, or hypoosmolar sugar solutions (for instance sucrose or inositol).
- the portion of saline buffer in the solution may be varied between 0 and almost 100%, whereby portions of 20%, 50%, or almost 100% are especially preferred.
- Inositol is preferably used as a 0.2 to 0.5 M solution, for instance of inositol in distilled water, especially preferred a 0.3 M solution.
- the portion of inositol solution and the solution according to the invention may also be varied between 0 and almost 100%. Especially preferred are indeed portions of 50%, 80%, and almost 100%.
- Polyvinyl alcohol with a molecular weight of between 30,000 g/mol and 70,000 g/mol is particularly well suited for the solution according to the invention, whereby the amount of PVA in the solution according to the invention lies between 0.1% (w/v) and 1.1% (w/v), preferably between 0.3% (w/v) and 0.6% (w/v), especially preferred between 0.45% (w/v) and 0.55% (w/v).
- the solution according to the invention may be utilized independent of type and properties of the particles, in particular for their examination and manipulation in microanalysis systems.
- the particles may be directly suspended in this solution and placed in the microanalysis system.
- this solution may be added to particle suspensions.
- the pH value of a 1% solution of polyvinyl alcohol in PBS was measured and lies at 7.31 (the physiologic pH range is pH 7.2-7.4).
- Jurkat-cells (clone E6-1 from the European Collection of Animal Cell Cultures, Salisbury, England) and U937-cells (monocytic cell line of the European Collection of Animal Cell Cultures, Salisbury, England) were cultivated in RPMI 1640 medium (GIBCO Life Technologies, Düsseldorf) by adding 100 IU/ml each of penicillin and streptomycin (Seromed/Biochrom, Berlin) and 10% fetal calf serum (Seromed/Biochrom, Berlin). 3 ml each of the cell suspension were centrifuged off and taken up in 300 ⁇ l of phosphate-buffered saline solution without calcium or magnesium (PBS, Seromed/Biochrom, Berlin).
- the wells of a 24-well plate (24-well polystyrene culture plates, Corning Costar) were each filled with 500 ⁇ l PBS by adding the table 3 indicated concentrations of the subsequently listed substances.
- Methylcellulose (15 and 4,000 centipoise viscosity of a 2% solution, SIGMA Aldrich GmbH, Steinheim), Ficoll 70 and Ficoll 400 (Pharmacia, Uppsala, Sweden), Dextran T10 (Pharmacia, Uppsala, Sweden), polyvinyl pyrrolidone 15 and 25 (Serva), polyethylene glycol 5,000 (Fluka) and polyvinyl alcohol 30,000-70,000 SIGMA Aldrich GmbH, Steinheim) were tested. 50 ⁇ l of the cell suspension described above were added. A sample in 500 ⁇ l cell culture medium (in which adherence of these suspension cells does not occur) served as control.
- Bovine serum albumin for instance, which is known from flow cytometry for the blocking of non-specific bonds and used in immunoreactive detection (e.g. Western blot technique).
- BSA bovine serum albumin
- various hydrophilic polymers that are used in density gradient centrifugation of blood samples or in cell culture techniques were examined. Even the influence of cadherins and integrins, specific cell-cell and cell-substrate adhesion molecules, in buffers without calcium and magnesium were examined. These molecules need calcium for interaction. It became apparent, that polyvinyl alcohol distinctly surpasses the other substances in the effect of successful preventing an adhesion of suspended cells on the sample carrier.
- the use of polyvinyl alcohol for the work with suspended cells in microchannels was examined with a CytoconTM 300 device system.
- the CytoconTM chips consist of glass and exhibit channels with a height of 40 ⁇ m, a width of 200-600 ⁇ m, and a length of about 1-2 cm, whereby specific embodiments of the chips may also exhibit electrodes in the channels.
- CytoconTM sorter chips comprise, for example, electrodes as dielectric junctions in the microchannels for the sorting of the suspended particles (in particular cells), in CytoconTM porator chips the electrodes are arranged in such a way, that cell fusion and/or cell poration can be carried out, and CytoconTM loader chips, that exhibit two electrode levels in a closed microchannel, a dielectric field cage in a channel intersection, as well as electrodes developed as dielectric junctions, are suitable for the performance of a stop-flow analysis as well as the subsequent sorting of the analyzed particles.
- Polyvinyl alcohol with a molecular weight of 30,000 g/mol to 70,000 g/mol was used.
- the polyvinyl alcohol was dissolved in the buffer to 0.5% (w/v) and was present during the entire manipulation of the cells in the microchannels.
- the cells were suspended in the buffer and injected into a CytoconTM chip.
- the suspension was transported within the channel system with a certain flow rate (“sample”) and at the chip exit accelerated with a sheath fluid.
- the rinsed out cells were counted and the recovery rate calculated from the initial concentration and the injected sample amount.
- the buffer contained 20% (v/v) PBS, 80% (v/v) 0.3 M inositol solution, and 0.5% (w/v) PVA (30,000-70,000, Sigma).
- the Jurkat cells were labeled with 10 ⁇ M Calcein-AMTM (Molecular Probes).
- the blood and the lymphoma cells were diluted as follows: The cell samples were mixed to concentrations of 2.5 ⁇ 10 6 Jurkat cells/ml and 1.8 ⁇ 10 7 red blood cells/ml. Samples of 0.3 ⁇ l were injected into a CytoconTM chip (microanalysis system).
- the CytoconTM chips used for this experiment consisted of glass and exhibited channels with a height of 40 ⁇ m, a width of 200-600 ⁇ m, and a length of about 1-2 cm. Additionally, the microanalysis system used here, comprised electrodes in one or several microchannels, that are arranged here as dielectric junction for the sorting of the cells.
- the cells were separated based on differences in their size and their dielectric properties via the so-called switch electrode (junction) of the CytoconTM microanalysis system at a frequency of the electric field of 800 kHz and an amplitude of 3-6 V rms at a flow rate of 62-240 ⁇ m/s. Under these conditions, the Jurkat cells were deflected and collected in fraction 1, while the red blood cells (RBC) could pass the junction and were collected in fraction 2.
- switch electrode junction
- Jurkat cells and red blood cells (RBC) were counted in both fractions in order to be able to determine the accumulation and the yield.
- the accumulation factor for the Jurkat cells in fraction 1 is in an exemplary experiment 17.5.
- the yield of Jurkat cells in this fraction was 93% in this case (table 2).
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Glass Compositions (AREA)
- Formation Of Insulating Films (AREA)
Abstract
Description
- This application is a Continuation of U.S. Ser. No. 483,218, filed Jan. 8, 2004, which is a National Stage Entry of PCT/EP02/07964, filed Jul. 17, 2002.
- The invention relates to a method for the prevention of the adhesion of particles, in particular of cells and cellular components, to surfaces, whereby a polyalcohol is added to the solution which contains the particles.
- The adherence to surfaces is a fundamental property of cells. This becomes apparent, for example, in the interaction of cells with an extracellular matrix, which is an important factor in controlling the gene expression or general cell function. These processes are influenced in particular via proteins on the cell surface.
- Indeed, this property of cells often presents a big problem during the preparation of cell cultures and the nondestructive examination of cells or cellular components. An adherence of cells to, for example, surfaces of the accessories and containers used in the preparation is undesirable. Technologies for the microanalysis of biological samples in particular can not be utilized for cell examinations without problems. These systems that contain, for example, canal systems like in the “Lab-on-Chip”-technology, often only have dimensions of a few micrometers. Furthermore, the selection of the surface materials to be used of these microanalysis systems is bound to the particular manufacturing process or the material of the microstructures in itself. Microchannel analysis systems, for example, are made from glass, silicon, silicone, and organic polymers, such as PMMA or polyurethane, all substrates that facilitate the adhesion of cells. The surface material consequently can not be freely chosen according to the requirements for a minimal cell adhesion.
- In order to prevent cell adherence/adhesion, the surface of the microstructures in itself is therefore modified. Various chemical compounds, in general hydrophobic silanes and hydrophilic polymers (hydrogels) are used for this purpose.
- Carlson et al. ((1997): “Self-Sorting of White Blood Cells in a Lattice” in “Physical Review Letters” 79, No. 11, p. 2149-2152) succeeded with the known coatings in the sorting of blood cells, for example, in mechanical microfilter systems. But white blood cells thereby irreversibly adhered to the entrances of microchannels. This is desirable in the described system, but at the same time shows the present limitations in the use of microchannels for the nondestructive examination of cellular samples.
- Further investigations by Li et al. (“Transport, Manipulation, and Reaction of Biological Cells On-Chip Using Electrokinetic Effects” in “Analytical Chemistry” (1997) 69, 1564-1568) showed that blood cells can be brought into 40 μm-wide microchannels. But the cells were subsequently lysed with a reagent and only then subjected to an analysis. However, the recovery of eukaryotic, particularly of living mammalian cells, from microchannels makes high demands on the selection of the surface materials of the channels.
- Further investigations, for example the coating of glass lamina with polyvinyl alcohol, showed that such a surface modification can minimize an adhesion of mouse fibroblast (Hisada, T. (1976): “The adhesion of culture cells to some polymers” (Japanese language) in “Shika Rikogaku Zasshi” 17(38), p. 91-101)).
- It could likewise be shown, that copolymer particles from poly(methyl methacrylate) and polyvinyl alcohol do not adhere to blood cells and are not phagocyted by monocytes and neutrophiles (Ayhan, H. and E. Piskin (1997): “Interaction of activated leukocytes with polymeric microspheres” in “International Journal of Artificial Organs” 20(12), 704-707).
- Krylov et al. (in “Electrophoresis”, 21, 767-773, 2000) furthermore found, that the adherence of cells to glass or polystyrene is markedly reduced, if the surfaces are modified with hydrophilic polymers (hydrogels) such as polyvinyl alcohol.
- However, in all the mentioned investigations, it is necessary to carry out a direct surface coating, whereby, for example, polyvinyl alcohol (PVA) is immobile bound to the surface, that is a surface coating or a copolymerization of a substrate with PVA is carried out. For the implementation of the coating, complicated, in particular to exact temperature specifications bound, multistep and thereby very time-consuming processes are necessary. Furthermore, particularly the coating of surfaces that consist of polymers such as polystyrene is problematic, since this material can be damaged by the temperatures of far above 100° C. that are necessary for the coating. The method can therefore only be satisfyingly applied to the use with glass surfaces.
- Furthermore, it is often impossible, in particular due to the only small diameters of the microstructures in microanalysis systems, to achieve a coating that is satisfying. Thus, for example, a uniform distribution of the polymers or other coating materials across the surfaces of the corresponding microstructures, for example of channel structures of a diameter of only a few micrometers, is not or only insufficiently possible.
- It is therefore the object of the present invention to develop a method, that independent of the nature and surface properties of a microanalysis system allows an essentially nondestructive and loss-free examination of particles, particularly of cells and cellular components, in solution in these Systems.
- The method comprises according to the invention the addition of a substance to the solution that contains the particles, particularly cells or cellular components, but also, for example, may contain proteins and peptides, that are present in the free form or bound to structures such as, for example beads. This substance according to the invention causes the adherence of these particles to surfaces, particularly surfaces of a microanalysis system, to be essentially prevented.
- In the only FIGURE, a diagram is shown that illustrates the recovery rate of suspended Jurkat cells from a microliter-syringe versus the residence time t in the presence of 0.5% PVA.
- According to the invention this substance involves a polyalcohol, in particular polyvinyl alcohol, for example polyvinyl alcohol VA 30,000-70,000 and/or polyglycol, preferably polyethylene glycol. Surprisingly, the addition of this substance to the solution did not show a toxic effect relating to living cells or does not cause change of cellular components. Especially suitable is a concentration of the polyalcohol in solution of 0.01% (w/v) to 5% (w/v). Considering polyvinyl alcohol as an example, it could even be shown, that the anti-adhesion effect of the polyalcohol by far exceeds that of known substances that are used as anti-adhesives (table 3). The water solubility and additional properties, listed below, of the polyalcohol cause a universal applicability in all aqueous particle solutions.
- An additional important property of this substance, that in particular qualifies it for the use in solutions which contain cells and/or cellular components, is that it has no influence on the physiologic pH-value of the solution.
- Many methods of analysis, that are applied in microanalysis systems, are based upon the recording and evaluation of optical signals, such as, for example, fluorescence correlation spectroscopy, fluorescence resonance energy transfer, fluorescence polarization, fluorescence intensity distribution analysis, or, for example, UV-spectroscopy. Therefore, it was all the more important for the universal applicability of this substance, that it does not influence an optical analysis, i.e. particularly does not show autofluorescence or change the refractive index of the solution. These requirements are very well met by polyalcohols, particularly polyvinyl alcohols or polyglycols.
- The method according to the invention now allows an essentially loss-free examination and manipulation, particularly separation, of the particles, particularly in microanalysis systems.
- Hereby it may concern microanalysis systems that have, for example, channels with a height of from 1-1,000 μm, particularly 2-500 μm, especially preferred 40 μm; a width of 100 -2,000 μm, particularly 200-600 μm, and a length of 100 μm-10 cm, preferably 1-2 cm. The systems may consist in particular of glass, silicon, silicone, organic polymers, or another suitable material. Specific embodiments of the microanalysis systems may also have electrodes, in particular for the generation of dielectric forces for the manipulation of the particles that are to be examined, for example for the microscopic, optical and/or electrical analyzing, for the sorting, separating, electroporating, fusing and separating of the particles, particularly of cells.
- Microanalysis systems, for example, thus comprise electrodes as dielectric junctions in the microchannels for the sorting of suspended particles (in particular cells), or in other microanalysis systems the electrodes are arranged in such a way that the cell fusion and/or cell poration can be carried out, and other systems comprise two electrode levels in a closed microchannel, a dielectric field cage in a channel intersection as well as electrodes developed as dielectric junctions for the implementation of a stop-flow analysis as well as a subsequent sorting of the analyzed particles. Whereby, the microchannel systems may also comprise combinations of the various electrode systems.
- Even the injection of the particles into such a system, which is often carried out with the help of a plastic or glass syringe, does no longer lead to losses, which are caused by the adherence of the particles to the syringe body.
- Since the added substance according to the invention also does not influence a living cell, it is, for example, possible, to directly examine cells, to sort on the basis of the examinations and then to specifically recreate cell cultures with the separated cells. That way, for example, cells with a certain property, for instance with a certain kind of receptors on the cell surface, are specifically and essentially loss-free separated from other cells and multiplied.
- The method according to the invention is in general suitable for all cell types, consequently both for eukaryotic cells and for prokaryotic cells.
- In table 1, the portion of living cells after the examination and/or manipulation in various microanalysis systems in the presence of polyvinyl alcohol is shown. (Jurkat-cells in Cytocon™ sorter chips (No. 1 and 2), in Cytocon™ porator chips (No. 3-5), and Cytocon™ loader chips (No. 6 and 7)).
-
TABLE 1 Flow Rate in μl/h Recovery Sheath Cell Amount Rate No. Sample fluid Per μl Total % 1 10 288 660 440 84 2 10 288 132 220 64 3 10 288 689 74 4 10 144 144 100 5 10 144 144 113 6 18 144 160 160 87.3 7 20 18 305 243 63 - In table 2, in each case, the portion of Jurkat-cells and blood cells in the
fractions -
TABLE 2 Number of Cells Total Fraction 1 Fraction 2Total Jurkat RBC Total Jurkat RBC Total Jurkat RBC 6,355 161 6,194 345 151 194 6,010 10 6000 100% 2.5% 97.5% 100% 43.8% 66.2% 100% 0.17% 99.8% - The method according to the invention is likewise suitable for cellular components. It has no influence on their structure and does not cause degeneration. Under cellular components are to be understood, for example, liposomes, lipid membranes, lipids, proteins, DNA, nucleic acids, messenger substances, sugar, glycans, and/or glycoproteins. In principle, all components of a cell are thus concerned, but also cell fragments.
- The method according to the invention provides, besides the advantage that it prevents an adherence of the particles to the surfaces of microanalysis systems, that may in particular consist of silicon, silicone, glass, and/or organic polymers such as PMMA, polyurethane, polycarbonate, polypropylene, polystyrene, polyethylene, polyvinyl chloride, Teflon®, polyacryl (fiber), nylon®, and/or perlon®, also the possibility that it prevents the adhesion of biomolecules, in particular cells, cell membranes, cellular components such as lipids, proteins (in particular antibodies), DNA, nucleic acids, messenger substances, biotin, sugar, glycans, and/or glycoproteins among one another or to surfaces coated with such molecules.
- In table 3, the cell adherence to polystyrene culture dishes in the presence of various substances is shown.
-
TABLE 3 Jurkat U937 Adherence Vitality Adherence Vitality RPMI — 97% 9 100% 10% FBS PBS 999 99% 999 98% PBS + 999 OK 999 OK Ca, Mg 0.1% BSA 99 OK 999 OK 0.5% BSA — OK 99 OK 1% PVP 15 99 100% 999 100% 1% PVP 25 99 100% 999 100% 1% PEG 99 100% 999 100% 5,000 1% MC 15 99 OK 999 OK 1% MC 400 99 OK 99 OK 10% Ficoll 999 OK 999 OK 70 10% Ficoll 999 OK 999 OK 400 10% 999 OK 999 OK Dextran T10 1% PVA — 97% (9) 98% 30,000- 70,000 0.1% PVA — OK (9) OK 30,000- 70,000 0.01% PVA — OK (9) OK 30,000- 70,000 Notes: — = no adherence (9) = very low adherence 9 = distinct adherence 99 = strong adherence 999 = very strong adherence OK = no quantification, but no difference to the control noticeable - Whereby within the meaning of this invention by surface is meant any surface, but in particular channel surfaces, surfaces of storage containers of microanalysis systems, tubing, syringes, injection modules, or surfaces of synthetic microparticles.
- Furthermore, a solution was found, that in general is suitable for the examination of particles, in particular of cells and cellular components in microanalysis systems. This solution contains saline buffer, in particular PBS, and/or inositol, and polyvinyl alcohol. However, to the solution may also be added other components known in the context of cell solutions such as, for example, magnesium and calcium ions.
- The portions of saline buffer, inositol, and/or PVA are variable. The buffer may be diluted in a variable mixing ratio by normoosmolar, hyperosmolar, or hypoosmolar sugar solutions (for instance sucrose or inositol). The portion of saline buffer in the solution may be varied between 0 and almost 100%, whereby portions of 20%, 50%, or almost 100% are especially preferred.
- Inositol is preferably used as a 0.2 to 0.5 M solution, for instance of inositol in distilled water, especially preferred a 0.3 M solution. Whereby, the portion of inositol solution and the solution according to the invention may also be varied between 0 and almost 100%. Especially preferred are indeed portions of 50%, 80%, and almost 100%.
- Polyvinyl alcohol with a molecular weight of between 30,000 g/mol and 70,000 g/mol is particularly well suited for the solution according to the invention, whereby the amount of PVA in the solution according to the invention lies between 0.1% (w/v) and 1.1% (w/v), preferably between 0.3% (w/v) and 0.6% (w/v), especially preferred between 0.45% (w/v) and 0.55% (w/v).
- The solution according to the invention may be utilized independent of type and properties of the particles, in particular for their examination and manipulation in microanalysis systems.
- For this purpose, the particles may be directly suspended in this solution and placed in the microanalysis system. However, it is also possible to add this solution to particle suspensions.
- The pH value of a 1% solution of polyvinyl alcohol in PBS was measured and lies at 7.31 (the physiologic pH range is pH 7.2-7.4).
- Jurkat-cells (clone E6-1 from the European Collection of Animal Cell Cultures, Salisbury, England) and U937-cells (monocytic cell line of the European Collection of Animal Cell Cultures, Salisbury, England) were cultivated in RPMI 1640 medium (GIBCO Life Technologies, Karlsruhe) by adding 100 IU/ml each of penicillin and streptomycin (Seromed/Biochrom, Berlin) and 10% fetal calf serum (Seromed/Biochrom, Berlin). 3 ml each of the cell suspension were centrifuged off and taken up in 300 μl of phosphate-buffered saline solution without calcium or magnesium (PBS, Seromed/Biochrom, Berlin). The wells of a 24-well plate (24-well polystyrene culture plates, Corning Costar) were each filled with 500 μl PBS by adding the table 3 indicated concentrations of the subsequently listed substances. Methylcellulose (15 and 4,000 centipoise viscosity of a 2% solution, SIGMA Aldrich GmbH, Steinheim), Ficoll 70 and Ficoll 400 (Pharmacia, Uppsala, Sweden), Dextran T10 (Pharmacia, Uppsala, Sweden), polyvinyl pyrrolidone 15 and 25 (Serva), polyethylene glycol 5,000 (Fluka) and polyvinyl alcohol 30,000-70,000 SIGMA Aldrich GmbH, Steinheim) were tested. 50 μl of the cell suspension described above were added. A sample in 500 μl cell culture medium (in which adherence of these suspension cells does not occur) served as control.
- The samples were incubated for 30 minutes at 37° C. The supernatant with non-adhered cells was removed and replaced by buffer. The adherence was qualitatively evaluated (refer to table 3). The cells in both supernatant and the wells were stained with trypanblue solution (0.2%, SIGMA Aldrich GmbH, Steinheim) in order to examine the vitality of the cells. Only polyvinyl alcohol has a very distinct inhibitory effect on the cell adherence with both cell lines. The effect already occurs at a concentration of 0.1% (w/v)
- Many substances, to which an anti-adhesive effect is assigned, were tested in comparison to polyvinyl alcohol. Bovine serum albumin (BSA), for instance, which is known from flow cytometry for the blocking of non-specific bonds and used in immunoreactive detection (e.g. Western blot technique). Furthermore, various hydrophilic polymers that are used in density gradient centrifugation of blood samples or in cell culture techniques were examined. Even the influence of cadherins and integrins, specific cell-cell and cell-substrate adhesion molecules, in buffers without calcium and magnesium were examined. These molecules need calcium for interaction. It became apparent, that polyvinyl alcohol distinctly surpasses the other substances in the effect of successful preventing an adhesion of suspended cells on the sample carrier.
- The use of 0.5% (w/v) of PVA for the recovery of cells from a microliter syringe was examined. Jurkat-cells were suspended in a concentration of 5.69×105 cells per ml in PBS with 0.5% PVA (w/v). 5 μl of this suspension were drawn up into a 5 μL-syringe (Dynatech). 1 μl each were transferred immediately and after 1 and 5 minutes, respectively, into a well of a Terasaki plate (NUNC, Wiesbaden). The cells were stained in the plate with the live/dead stain kit (Molecular Probes, Leiden, Netherlands) and counted; thereby their vitality was simultaneously examined. The recovery rate was determined.
- More than 90% of the cells could be recovered—after 5 minutes as well—from the syringe. They therefore had not adhered. The percentage of dead cells initially, thus at 0 minutes, amounted to 0.8% and increased after 5 minutes only to 2.4%.
- The use of polyvinyl alcohol for the work with suspended cells in microchannels was examined with a Cytocon™ 300 device system. The Cytocon™ chips consist of glass and exhibit channels with a height of 40 μm, a width of 200-600 μm, and a length of about 1-2 cm, whereby specific embodiments of the chips may also exhibit electrodes in the channels. Cytocon™ sorter chips comprise, for example, electrodes as dielectric junctions in the microchannels for the sorting of the suspended particles (in particular cells), in Cytocon™ porator chips the electrodes are arranged in such a way, that cell fusion and/or cell poration can be carried out, and Cytocon™ loader chips, that exhibit two electrode levels in a closed microchannel, a dielectric field cage in a channel intersection, as well as electrodes developed as dielectric junctions, are suitable for the performance of a stop-flow analysis as well as the subsequent sorting of the analyzed particles.
- Polyvinyl alcohol with a molecular weight of 30,000 g/mol to 70,000 g/mol was used. The polyvinyl alcohol was dissolved in the buffer to 0.5% (w/v) and was present during the entire manipulation of the cells in the microchannels.
- The cells were suspended in the buffer and injected into a Cytocon™ chip. The suspension was transported within the channel system with a certain flow rate (“sample”) and at the chip exit accelerated with a sheath fluid. The rinsed out cells were counted and the recovery rate calculated from the initial concentration and the injected sample amount.
- Even though the cell amount used was only a few hundred cells and the flow rate in the microchannels was very slow (dwell time of the cells in the microchannel about 2 minutes), the recovery rate of cells was very high (table 1) and values around 100% were achievable.
- A mixture of whole human blood, Jurkat T-lymphoma cells, and a PVA-containing buffer was prepared. The buffer contained 20% (v/v) PBS, 80% (v/v) 0.3 M inositol solution, and 0.5% (w/v) PVA (30,000-70,000, Sigma). For a better visualization during the experiment, the Jurkat cells were labeled with 10 μM Calcein-AM™ (Molecular Probes).
- The blood and the lymphoma cells were diluted as follows: The cell samples were mixed to concentrations of 2.5·106 Jurkat cells/ml and 1.8·107 red blood cells/ml. Samples of 0.3 μl were injected into a Cytocon™ chip (microanalysis system).
- The Cytocon™ chips used for this experiment consisted of glass and exhibited channels with a height of 40 μm, a width of 200-600 μm, and a length of about 1-2 cm. Additionally, the microanalysis system used here, comprised electrodes in one or several microchannels, that are arranged here as dielectric junction for the sorting of the cells.
- The cells were separated based on differences in their size and their dielectric properties via the so-called switch electrode (junction) of the Cytocon™ microanalysis system at a frequency of the electric field of 800 kHz and an amplitude of 3-6 V rms at a flow rate of 62-240 μm/s. Under these conditions, the Jurkat cells were deflected and collected in
fraction 1, while the red blood cells (RBC) could pass the junction and were collected infraction 2. - Jurkat cells and red blood cells (RBC) were counted in both fractions in order to be able to determine the accumulation and the yield.
- The accumulation factor for the Jurkat cells in
fraction 1 is in an exemplary experiment 17.5. The yield of Jurkat cells in this fraction was 93% in this case (table 2). - Overall (
fractions 1 and 2), the cell recovery rate was almost 100%.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/854,792 US20080113333A1 (en) | 2001-07-27 | 2007-09-13 | Method for preventing the adhesion of particles |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10136722.8 | 2001-07-27 | ||
DE10136722A DE10136722A1 (en) | 2001-07-27 | 2001-07-27 | Inhibiting adhesion of particles to surfaces, useful e.g. for preventing cell adhesion in microanalytical systems, comprises adding polyol to a working solution |
PCT/EP2002/007964 WO2003012077A1 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
US10/483,218 US7300793B2 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
US11/854,792 US20080113333A1 (en) | 2001-07-27 | 2007-09-13 | Method for preventing the adhesion of particles |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/007964 Continuation WO2003012077A1 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
US10/483,218 Continuation US7300793B2 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080113333A1 true US20080113333A1 (en) | 2008-05-15 |
Family
ID=7693354
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/483,218 Expired - Lifetime US7300793B2 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
US11/854,792 Abandoned US20080113333A1 (en) | 2001-07-27 | 2007-09-13 | Method for preventing the adhesion of particles |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/483,218 Expired - Lifetime US7300793B2 (en) | 2001-07-27 | 2002-07-17 | Method for preventing the adhesion of particles |
Country Status (6)
Country | Link |
---|---|
US (2) | US7300793B2 (en) |
EP (1) | EP1412480B1 (en) |
JP (1) | JP4663979B2 (en) |
AT (1) | ATE399201T1 (en) |
DE (2) | DE10136722A1 (en) |
WO (1) | WO2003012077A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080241270A1 (en) * | 2007-03-30 | 2008-10-02 | Neal Robert A | Fluid composition for inhibiting surgical adhesion formation and related method of production |
KR101461652B1 (en) * | 2011-12-16 | 2014-11-21 | 주식회사 삼양바이오팜 | Composition for anti-adhesion, surgical mesh composite with anti-adhesion property comprising the same and method for producing thereof |
KR102160834B1 (en) * | 2014-12-26 | 2020-09-29 | 효성티앤씨 주식회사 | A process for preparing spandex fiber with exellent unwinding property |
EP3536402A1 (en) | 2018-03-09 | 2019-09-11 | Ibidi Gmbh | Sample chamber |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229366A (en) * | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
US5241022A (en) * | 1991-01-22 | 1993-08-31 | Shin-Etsu Chemical Co., Ltd. | Coating solution for preventing adhesion of polymer scale and method for preventing scale adhesion during preparation of polymers |
US5958443A (en) * | 1991-10-30 | 1999-09-28 | Mdv Technologies, Inc. | Medical uses of in situ formed gels |
US5977252A (en) * | 1996-03-07 | 1999-11-02 | University Of Pittsburgh | Covalent modification of surfaces with polymers to increase biocompatibility |
US20020155241A1 (en) * | 2001-02-26 | 2002-10-24 | Tarasevich Barbara J. | Surface modifications of medical devices to reduce protein adsorption |
US20030180251A1 (en) * | 2000-08-02 | 2003-09-25 | Volker Friedrich | Medical technical product, method for producing the same and providing the same for surgery |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2620728B2 (en) * | 1990-10-23 | 1997-06-18 | 富士写真フイルム株式会社 | Peptide-containing polyethylene glycol derivatives and their uses |
JPH04187698A (en) * | 1990-11-21 | 1992-07-06 | Fuji Photo Film Co Ltd | Peptide-containing polyethylene glycol derivative and its use |
JPH04316483A (en) * | 1991-04-17 | 1992-11-06 | Nitsusui Seiyaku Kk | Serumless synthetic medium for suspended cell |
US5413732A (en) * | 1991-08-19 | 1995-05-09 | Abaxis, Inc. | Reagent compositions for analytical testing |
JP3171560B2 (en) * | 1996-05-21 | 2001-05-28 | 仁 苅野 | Heteropolyacid catalyst |
FR2762314B1 (en) * | 1997-04-17 | 1999-06-18 | Rhodia Chimie Sa | PROCESS FOR THE PREPARATION OF AROMATIC ALDEHYDES |
US6743521B2 (en) * | 1997-04-21 | 2004-06-01 | California Institute Of Technology | Multifunctional polymeric tissue coatings |
JP2002507908A (en) * | 1997-06-26 | 2002-03-12 | スミス アンド ネフュー ピーエルシー | Cell culture products |
DE19912798C1 (en) * | 1999-03-10 | 2000-02-17 | Andreas Jordan | Culturing human cancer cells for molecular biology research comprises culturing fragments of tissue slices |
DE10117099A1 (en) * | 2000-08-02 | 2002-02-21 | Aesculap Ag & Co Kg | Medical technology product, process for its production and provision for surgery |
-
2001
- 2001-07-27 DE DE10136722A patent/DE10136722A1/en not_active Ceased
-
2002
- 2002-07-17 WO PCT/EP2002/007964 patent/WO2003012077A1/en active IP Right Grant
- 2002-07-17 EP EP02762371A patent/EP1412480B1/en not_active Expired - Lifetime
- 2002-07-17 JP JP2003517255A patent/JP4663979B2/en not_active Expired - Lifetime
- 2002-07-17 DE DE50212410T patent/DE50212410D1/en not_active Expired - Lifetime
- 2002-07-17 AT AT02762371T patent/ATE399201T1/en not_active IP Right Cessation
- 2002-07-17 US US10/483,218 patent/US7300793B2/en not_active Expired - Lifetime
-
2007
- 2007-09-13 US US11/854,792 patent/US20080113333A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229366A (en) * | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
US5241022A (en) * | 1991-01-22 | 1993-08-31 | Shin-Etsu Chemical Co., Ltd. | Coating solution for preventing adhesion of polymer scale and method for preventing scale adhesion during preparation of polymers |
US5958443A (en) * | 1991-10-30 | 1999-09-28 | Mdv Technologies, Inc. | Medical uses of in situ formed gels |
US5977252A (en) * | 1996-03-07 | 1999-11-02 | University Of Pittsburgh | Covalent modification of surfaces with polymers to increase biocompatibility |
US20030180251A1 (en) * | 2000-08-02 | 2003-09-25 | Volker Friedrich | Medical technical product, method for producing the same and providing the same for surgery |
US20020155241A1 (en) * | 2001-02-26 | 2002-10-24 | Tarasevich Barbara J. | Surface modifications of medical devices to reduce protein adsorption |
Also Published As
Publication number | Publication date |
---|---|
JP2004535828A (en) | 2004-12-02 |
EP1412480A1 (en) | 2004-04-28 |
US7300793B2 (en) | 2007-11-27 |
WO2003012077A1 (en) | 2003-02-13 |
DE50212410D1 (en) | 2008-08-07 |
US20040175354A1 (en) | 2004-09-09 |
EP1412480B1 (en) | 2008-06-25 |
JP4663979B2 (en) | 2011-04-06 |
DE10136722A1 (en) | 2003-02-13 |
ATE399201T1 (en) | 2008-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Monguió‐Tortajada et al. | Extracellular‐vesicle isolation from different biological fluids by size‐exclusion chromatography | |
EP0756709B1 (en) | Method of selection of a population or subpopulation of a sample | |
DE69818650T2 (en) | DEVICE AND METHODS FOR INTAKE AND ANALYSIS OF PARTICLE UNITS | |
US5985153A (en) | Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force | |
US8030069B2 (en) | Materials and procedures for the purification of cells | |
US20140302483A1 (en) | Cell separation method | |
WO1995028643A9 (en) | Method of selection of a population or subpopulation of a sample | |
WO1997046882A9 (en) | Magnetic separation employing external and internal gradients | |
EP2045601A1 (en) | Use of microcarrier beads for detection and/or isolation of cells by flow cytometry and/or dielectrophoresis | |
EP0877941B1 (en) | Method for bulk enrichment of a population or subpopulation of cells | |
AU704197B2 (en) | High efficiency method for isolating target substances using a multisample separation device | |
US20080113333A1 (en) | Method for preventing the adhesion of particles | |
Baumgarten | A simple microplate assay for the determination of cellular protein | |
Chalmers et al. | Theoretical analysis of cell separation based on cell surface marker density | |
Shortman | Separation methods for lymphocyte populations | |
Sekine et al. | Panning of multiple subsets of leukocytes on antibody-decorated poly (ethylene) glycol-coated glass slides | |
Wang et al. | Isolation and counting of multiple cell types using an affinity separation device | |
Mackenzie et al. | Flow cytometry and its applications in veterinary medicine | |
Hedlund et al. | Evidence for the existence of W3/13+ monocytes in the rat | |
Elliott | A sensitive method for the separation of rosette-forming cells | |
FI78362B (en) | FOERFARANDE OCH KOMPOSITION FOER ISOLERING AV VITCELLSKOMPONENTER. | |
US20060134597A1 (en) | Apparatus and method for rapid separation of cells without using density gradient and antibodies | |
CN115718028A (en) | Hemolysin for analysis of flow cytometer and preparation method thereof | |
Tekstra et al. | Detection of CD 14 on migrated monocytes by specific antibody: a possible quantification for blood monocyte chemotaxis | |
Leipzig et al. | Cytomics and the Human Cytome Project |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EVOTEC OAI AG, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GRADL, GABRIELE;REEL/FRAME:026966/0068 Effective date: 20031219 Owner name: PERKINELMER CELLULAR TECHNOLOGIES GERMANY GMBH, GE Free format text: CHANGE OF NAME;ASSIGNOR:EVOTEC TECHNOLOGIES GMBH;REEL/FRAME:026973/0543 Effective date: 20070621 Owner name: EVOTEC TECHNOLOGIES GMBH, GERMANY Free format text: CHANGE OF NAME;ASSIGNOR:EVOTEC OAI AG;REEL/FRAME:026966/0148 Effective date: 20070621 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |